# Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients

> **NCT02798107** · — · WITHDRAWN · sponsor: **Boehringer Ingelheim**

## Conditions studied

- Hemorrhage

## Interventions

- **DRUG:** idarucizumab

## Key facts

- **NCT ID:** NCT02798107
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-20
- **Primary completion:** 2019-05-23
- **Final completion:** 2019-05-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No recruitment
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798107, "Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02798107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*